Edesa Biotech

View the org chart displaying its 10 main executives

Most searched biographies at Edesa Biotech

• Par Nijhawan, Chief Executive Officer and Director
• Frank Oakes, Board Director
• Patrick Marshall, Director

Create your alert
to follow the executive moves at Edesa Biotech.

Edesa Biotech has 2,282 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Edesa Biotech

• News | Edesa Biotech, Inc. (Nasdaq: EDSA)

Social media about Edesa Biotech

• Edesa Biotech on Wikipedia, Google News & Yahoo Finance
• Edesa Biotech on LinkedIn, Twitter & YouTube

Contact by email its executives including Par Nijhawan

Call Edesa Biotech at +1 289...

View the org chart

Register to receive your alert

Report an error